HCA Healthcare, Inc. (HCA) stock
HCANYSEServices-General Medical & Surgical Hospitals, NECFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 10/302% below fair value
$511.78+12.73 (+2.55%)
Close on Nov 16, 2026Market cap $106.91BP/E 17.0Yield 0.56%
HCA Healthcare price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
HCA Healthcare's price to sales ratio was 1.4× on Nov 11, 2026, against 1.6× a year earlier. Over the last 5 years it ranged from 0.8× to 1.6×, with a median of 1.2×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 1.4× | −0.0 |
| 2025 | Dec 31, 2025 | 1.4× | +0.3 |
| 2024 | Dec 31, 2024 | 1.1× | −0.1 |
| 2023 | Dec 29, 2023 | 1.2× | +0.0 |
| 2022 | Dec 30, 2022 | 1.1× | −0.3 |
| 2021 | Dec 31, 2021 | 1.4× | +0.3 |
| 2020 | Dec 31, 2020 | 1.1× | +0.1 |
| 2019 | Dec 31, 2019 | 1.0× | +0.1 |
| 2018 | Dec 31, 2018 | 0.9× | +0.2 |
| 2015 | Oct 30, 2015 | 0.7× | −0.1 |
| 2014 | Dec 31, 2014 | 0.9× | +0.2 |
| 2013 | Dec 31, 2013 | 0.6× | +0.2 |
| 2012 | Dec 31, 2012 | 0.4× | +0.1 |
| 2011 | Dec 30, 2011 | 0.3× | – |
See a number that looks wrong?